Archive for May 2023
The Petri Dish: Biogen Alzheimer’s drug could cost Medicare $5B a year; KSQ strikes $510M+ deal with Takeda
Leqembi, the Alzheimer’s disease drug made by Eisai Inc. and partner Biogen, could cost Medicare up to $5 billion a year, based on new research. Read More
Read MoreHarvard Pilgrim says a fix may still be weeks away a month after cyberattack
The health insurer says it’s still working to restore function and expects it may be weeks before some of its core systems are back online. Read More
Read MoreEditorial: Communities should adopt the Massport model themselves
With states like Florida rolling back DEI initiatives, Massachusetts communities have an opportunity to attract project proposals that align with values on the proper side of history. Read More
Read MoreFAST 50: FreightPlus surges as businesses seek shipping help
The Quincy company has been a beneficiary of the turmoil around the global supply chain. Read More
Read MoreFAST 50: IntelyCare makes ‘platform of choice’ to keep nurses at bedside
IntelyCare tries to provide flexibility to nurses, as well as a platform to providers to manage more versatile shifts. Read More
Read MoreFAST 50: Staffing firms find room to grow in tight labor market
Recruiting and staffing firms in the Boston area are finding plenty of work amid a tight labor market by connecting corporate clients to would-be employees. Read More
Read MoreBoston Business Journal unveils its ranked Fast 50
The Boston Business Journal unveiled its Fast 50 honorees at an event at the Westin Copley Place on Wednesday evening. Here are the honorees in order by growth. Read More
Read MoreFAST 50: Helping make software faster leads to fast growth
The company helps highly regulated firms develop software or mobile apps faster through a combination of proprietary tools and consulting services. Read More
Read MoreA look at Worcester’s housing development under Ed Augustus
Many of the housing developments approved or built during Augustus’s tenure came with the aid of historic tax credits, municipal tax breaks, or both. Read More
Read MoreEditas loses another executive — the 9th in 5 years — amid new focus
Four months after it trimmed its pipeline down to a handful of drugs for blood disorders, Editas Medicine Inc. has a new chief financial officer to help oversee the new strategy. Read More
Read More